Advisory Services Network, LLC Adaptimmune Therapeutics PLC Transaction History

Advisory Services Network, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$0.43 - $0.79 $53 - $98	125 New	125 $0
Q4 2022 Feb 13, 2023	BUY	$1.05 - $2.53 $341 - $822	325 New	325 $0
Q1 2021 May 24, 2021	SELL	$4.9 - $6.83 $833 - $1,161	-170 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$7.66 - $10.78 $1,302 - $1,832	170 New	170 $1,000
Q2 2020 Aug 10, 2020	SELL	$2.58 - $12.1 $258 - $1,210	-100 Closed	0 $0
Q4 2018 Feb 15, 2019	SELL	$3.76 - $14.16 $240 - $906	-64 Reduced 39.02%	100 $1,000
Q2 2018 Jul 27, 2018	BUY	$10.42 - $13.74 $666 - $879	64 Added 64.0%	164 $2,000
Q2 2017 Aug 17, 2017	BUY	N/A	100	100 $0

152M

78.5K

36.5K

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $121M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.